BE756973A - Hydroxyphenyl-2-piperidinylcarbinols et compositions pharmaceutiques encontenant - Google Patents

Hydroxyphenyl-2-piperidinylcarbinols et compositions pharmaceutiques encontenant

Info

Publication number
BE756973A
BE756973A BE756973DA BE756973A BE 756973 A BE756973 A BE 756973A BE 756973D A BE756973D A BE 756973DA BE 756973 A BE756973 A BE 756973A
Authority
BE
Belgium
Prior art keywords
piperidinylcarbinols
hydroxyphenyl
pharmaceutical compositions
compositions containing
pharmaceutical
Prior art date
Application number
Other languages
English (en)
French (fr)
Inventor
C Kaiser
S T Ross
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication date
Publication of BE756973A publication Critical patent/BE756973A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/02Preparation by ring-closure or hydrogenation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
BE756973D 1969-10-08 Hydroxyphenyl-2-piperidinylcarbinols et compositions pharmaceutiques encontenant BE756973A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86486569A 1969-10-08 1969-10-08

Publications (1)

Publication Number Publication Date
BE756973A true BE756973A (fr) 1971-04-02

Family

ID=25344244

Family Applications (1)

Application Number Title Priority Date Filing Date
BE756973D BE756973A (fr) 1969-10-08 Hydroxyphenyl-2-piperidinylcarbinols et compositions pharmaceutiques encontenant

Country Status (10)

Country Link
JP (1) JPS4811101B1 (de)
BE (1) BE756973A (de)
CA (1) CA958718A (de)
DE (1) DE2047937A1 (de)
FR (1) FR2070113B1 (de)
GB (1) GB1278368A (de)
KE (1) KE2564A (de)
LU (1) LU61827A1 (de)
MY (1) MY7500242A (de)
ZA (1) ZA706324B (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6664424B2 (en) 1998-07-01 2003-12-16 Warner-Lambert Company Stereoisomers with high affinity for adrenergic receptors
US7232837B2 (en) 1999-06-29 2007-06-19 Mcneil-Ppc, Inc. Stereoisomers with high affinity for adrenergic receptors

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA960676A (en) * 1970-05-21 1975-01-07 Smith Kline And French Canada Ltd. 3-sulfonamido-4-hydroxyphenyl-2-piperidinylcarbinols
GB0604826D0 (en) * 2006-03-09 2006-04-19 Arakis Ltd The treatment of inflammatory disorders and pain

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE569836A (de) *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6664424B2 (en) 1998-07-01 2003-12-16 Warner-Lambert Company Stereoisomers with high affinity for adrenergic receptors
US7232837B2 (en) 1999-06-29 2007-06-19 Mcneil-Ppc, Inc. Stereoisomers with high affinity for adrenergic receptors

Also Published As

Publication number Publication date
CA958718A (en) 1974-12-03
GB1278368A (en) 1972-06-21
ZA706324B (en) 1971-04-28
FR2070113B1 (de) 1974-05-24
DE2047937A1 (de) 1971-04-22
JPS4811101B1 (de) 1973-04-10
LU61827A1 (de) 1971-04-29
KE2564A (en) 1975-09-19
MY7500242A (en) 1975-12-31
FR2070113A1 (de) 1971-09-10

Similar Documents

Publication Publication Date Title
PH11097A (en) Xanthone derivative and pharmaceutical composition
BE772190A (fr) Nouvelles compositions pharmaceutiques
BE752620A (fr) Composition antiseptique
BE766589A (fr) Composition et produit photosensibles et thermodeveloppables
FI54314C (fi) Foerfarande foer framstaellning av pyrimidin- och 6-azapyrimidinnukleosider
MC869A1 (fr) Furanosyl-aminopurines et médicament contenant ces substances
BE752165A (fr) Preparations pharmaceutiques anesthesiques
BE782981A (fr) Compositions pharmaceutiques
BE749864A (fr) Nouvelle composition pharmaceutique effervescente
BE775640A (fr) Composition pharmaceutique
BE782444A (fr) Compositions pharmaceutiques
BE758969A (fr) Alcoyl-adamantanes et leur preparation
BE777158A (fr) Compositions pharmaceutiques encapsulees
BE756973A (fr) Hydroxyphenyl-2-piperidinylcarbinols et compositions pharmaceutiques encontenant
BE782065A (fr) Compositions pharmaceutiques et veterinaires
BE764768A (fr) Compositions pharmaceutiques
BE746505A (fr) Benzene-sulfonyl-uree et sa preparation
BE774033A (fr) Compositions pharmaceutiques anti-allergiques
BE770399A (fr) Composition pharmaceutique
BE772487A (fr) Compositions pharmaceutiques
IL35053A0 (en) 3-amino-delta2-pyrazoline derivatives,their preparation and pharmaceutical compositions and photographic agents containing them
PH10499A (en) 2-amidopenicillins and pharmaceutical compositions containing them
BE744083A (fr) Nouvelles preparations pharmaceutiques
BE745022A (fr) Composition pharmaceutique
BE756792A (fr) Poly-organosiloxanes modifies et leur preparation

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: SMITH KLINE & FRENCH LABORATORIES

Effective date: 19901002